translation agency

NLM AIDSLINE
Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.
Wiedermann U; Jahn-Schmid B; Lindblad M; Rask C; Holmgren J; Kraft D;
November 30, 1999
Int Immunol. 1999 Jul;11(7):1131-8. Unique Identifier : AIDSLINE

Recent reports have demonstrated that feeding small amounts of antigen conjugated to the B subunit of cholera toxin (CTB) suppress immune responses in experimental models of certain Th1-based autoimmune diseases. We have established a model of aerosol sensitization leading to Th2-mediated allergic immune responses in BALB/c mice. In the present study two different antigens, the dietary antigen ovalbumin (OVA) and the inhalant allergen Bet v 1 (the major birch pollen allergen), chemically coupled to recombinant CTB were tested for their potential to influence Th2-like immune responses. Intranasal administration of OVA-CTB prior to sensitization with OVA led to a significant decrease of antigen-specific IgE antibody levels, but a marked increase of OVA-specific IgG2a antibodies as compared to non-pretreated, sensitized animals. Antigen-specific lympho-proliferative responses in vitro were reduced by 65% in the pretreated group; IL-5 and IL-4, but not IFN-gamma, production were markedly decreased in responder cells of lungs and spleens of nasally pretreated mice. In contrast, mucosal administration of rBet v 1-CTB conjugates prior to sensitization led to an up-regulation of allergen-specific IgE, IgG1 and IgG2a, increased in vitro lympho-proliferative responses as well as augmented production of IL-5, IL-4, IL-10 and IFN-gamma. Intranasal administration prior to sensitization of unconjugated allergens showed also contrasting effects: OVA could not significantly influence antigen-specific antibody or cytokine production, whereas intranasal pretreatment with unconjugated Bet v 1 suppressed allergen-specific immune responses in vivo and in vitro. These results demonstrated that the two antigens--in conjugated as in unconjugated form--had different effects on the Th2 immune responses. We therefore conclude that the tolerogenic or immunogenic properties of CTB--and probably also other antigen-delivery systems--strongly depend on the nature of the coupled antigen-allergen.

JOURNAL ARTICLE Adjuvants, Immunologic/*ADMINISTRATION & DOSAGE Administration, Intranasal Animal Comparative Study Cytokines/BIOSYNTHESIS *Desensitization, Immunologic Disease Models, Animal Female Hypersensitivity, Immediate/*IMMUNOLOGY/METABOLISM/THERAPY Immunity, Mucosal/IMMUNOLOGY Immunoconjugates/*IMMUNOLOGY Interleukin-4/BIOSYNTHESIS Interleukin-5/BIOSYNTHESIS Lymphocyte Transformation/IMMUNOLOGY Mice Mice, Inbred BALB C Ovalbumin/*IMMUNOLOGY Plant Proteins/*IMMUNOLOGY Support, Non-U.S. Gov't Th2 Cells/IMMUNOLOGY Toxoids/*IMMUNOLOGY

www.aegis.org